Saint Sean
President & CEO
Saint Sean has filed 6 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Sep 4, 2026.
On the most recent filing, Saint Sean is listed as President & CEO at Beta Bionics, Inc. Inside the rolling window, Saint Sean reported no open-market purchases and 5 open-market sales totaling $786K in BBNX. The largest disclosed transaction in the window is a sale of 16,867 BBNX shares on Sep 2, 2026, worth $322K.
Companies traded
Other insiders at BBNX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$786K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 2, 2025 | BBNX | Sale | $63K |
Frequently asked questions
How many SEC Form 4 filings has Saint Sean made?
Saint Sean has filed 6 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does Saint Sean trade?
Saint Sean has filed SEC Form 4 disclosures for 1 company, including BBNX.
When was Saint Sean's most recent SEC Form 4 filing?
Saint Sean's most recent SEC Form 4 filing on Tracefour is dated Sep 4, 2026.
What is Saint Sean's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Saint Sean is listed as President & CEO.
What is Saint Sean's total buy and sell value in the current window?
Inside the rolling retention window, Saint Sean bought $0 and sold $786K based on SEC Form 4 filings.
What was Saint Sean's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 16,867 BBNX shares on 2026-09-02, worth $322K, per SEC Form 4 filings.